CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer.
Dalerba P, Sahoo D, Paik S, Guo X, Yothers G, Song N, Wilcox-Fogel N, Forgó E, Rajendran PS, Miranda SP, Hisamori S, Hutchison J, Kalisky T, Qian D, Wolmark N, Fisher GA, van de Rijn M, Clarke MF.
Dalerba P, et al. Among authors: hisamori s.
N Engl J Med. 2016 Jan 21;374(3):211-22. doi: 10.1056/NEJMoa1506597.
N Engl J Med. 2016.
PMID: 26789870
Free PMC article.